Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net loss	$ (2,891,421)	$ (2,452,290)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation and amortization	431	415
Amortization of prepaid expense	377,768	451,090
Stock-based compensation	290,350	1,272,502
Amortization of debt discount	69,899	30,610
Loss on settlement of debt	(1,939,577)	(639,690)
Initial derivative expense	(112,116)	(100,554)
Change in fair value of derivative liabilities	68,613	185,567
Change in operating assets and liabilities
Accounts and taxes receivable	39,083	446
Accounts payable and accrued liabilities	108,854	13,720
Net cash used in operating activities	(100,122)	(129,722)
Cash flows from investing activities
Purchase of property and equipment		1,417
Net cash used in investing activities		(1,417)
Cash flow from financing activities
Advance by related party	18,203	19,196
Repayment of advances to related party	20,505	11,627
Proceeds from notes payable	7,860	84,144
Repayments of notes payable		58,882
Proceeds from promissory notes	19,217
Proceeds from non-redeemable convertible	15,823
Proceeds from convertible notes	150,000	100,000
Net cash provided by financing activities	190,598	132,831
Change in foreign exchange	79
Net change in cash, cash equivalents, and restricted	90,555	1,692
Cash, cash equivalents, and restricted cash beginning of the period	21,843	293
Cash, cash equivalents, and restricted cash end of the period	112,398	1,985
Cash paid during the year: Interest paid
Cash paid during the year: Income taxes paid
Supplemental disclosure of non-cash investing and financing activities
Stock issued to settle accrued liabilities	110,000
Stock issued to settle non-redeemable convertible notes	1,964,621	592,224
Stock issued to settle convertible notes	218,126	208,285
Initial debt discount from derivative	150,000	100,000
Transfer of advances to promissory notes	$ 23,047